Figure 3.

Propensity score matched incidence rates and hazard ratios of stroke/systemic embolism (SE) and major bleeding for non–vitamin K antagonist oral anticoagulants (NOACs) vs NOACs. CI, confidence interval; GI, gastrointestinal; ICH, intracranial hemorrhage; SE, systemic embolism.

Note: Cells with 10 or fewer observations were redacted. The components of stroke/SE and major bleeding are not mutually exclusive, and therefore the component values do not add up to the overall number of stroke/SE and major bleeding events.